FIELD: chemistry.
SUBSTANCE: present invention relates to phenylalanine derivatives and their pharmaceutically acceptable salts. In formula (1) R11 is a hydroxyl group, an alkoxyl group having 1-6 carbon atoms, which can be substituted with a methoxy group, cycloalkoxyl group having 3-6 carbon atoms, or a benzyloxy group; R12 and R13 each independently represents a hydrogen atom, alkyl group having 1-6 carbon atoms, cycloalkyl group having 3-6 carbon atoms, acetyl group or methyloxycarbonyl group, or N(R12)R13 is a 1-pyrrolidinyl group, 1-piperidinyl group, 4-morpholinyl group; R14 is a methyl group; R1' is a hydrogen atom, fluorine atom; X1 is -CH(R1a)-, -CH(R1a)CH(R1b)-, -CH(R1a)CH(R1b)CH(R1c)-, -N(R1a)CH(R1b)CH(R1c)-, -OCH(R1a)CH(R1b)-, -OCH(R1a)CH(R1b)CH(R1c)- or 1,3-pyrrolidinylene, where R1a, R1b, each independently represents a hydrogen atom or a methyl group, and R1c is a hydrogen atom; Y11 and Y12 represent any of the combinations (CI, Cl), (CI, Me), (CI, F). Invention also relates to phenylalanine derivatives of formulae (2)-(14), given in the formula of invention.
EFFECT: obtaining a pharmaceutical composition having antagonistic effect on α4-integrin, containing a phenylalanine derivative as an active ingredient, a α4-integrin antagonist and a therapeutic agent.
65 cl, 51 tbl, 244 ex
Title | Year | Author | Number |
---|---|---|---|
NOVEL DERIVATIVES OF PHENYLALANINE | 2001 |
|
RU2286340C2 |
METHOD OF PRODUCING PHENYLALANINE DERIVATIVES WITH QUINAZOLINEDIONE SKELETON AND INTERMEDIATE COMPOUNDS USED TO PRODUCE SAID COMPOUNDS | 2007 |
|
RU2469028C2 |
NOVEL IMIDAZOOXAZINE COMPOUND OR SALT THEREOF | 2012 |
|
RU2578608C2 |
NOVEL DERIVATIVES OF ASPARTYL DIPEPTIDE ESTER AND SWEETENING AGENTS | 1999 |
|
RU2192430C2 |
EGFR INHIBITOR | 2021 |
|
RU2817044C1 |
AZAINDOLE DERIVATIVE | 2015 |
|
RU2649575C1 |
PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS AND THERAPEUTIC APPLICATIONS THEREOF | 2016 |
|
RU2718915C2 |
NEW PIPERIDINE COMPOUND OR SALT THEREOF | 2013 |
|
RU2581834C1 |
ANTITUMOR EFFECT AMPLIFYER CONTAINING IMIDAZOOXAAZINE COMPOUND | 2013 |
|
RU2618423C2 |
COMBINATIVE MEDICINAL AGENT | 2003 |
|
RU2328280C2 |
Authors
Dates
2010-05-27—Published
2004-12-22—Filed